Effects of naltrexone on pain sensitivity and mood in fibromyalgia: no evidence for endogenous opioid pathophysiology.
The pathophysiological mechanisms underlying fibromyalgia are still unknown, although some evidence points to endogenous opioid dysfunction. We examined how endogenous opioid antagonism affects pain and mood for women with and without fibromyalgia. Ten women with fibromyalgia and ten age- and gender...
Guardado en:
Autores principales: | Jarred W Younger, Alex J Zautra, Eric T Cummins |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2009
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2d2e172792ad4062aa220fc25513b91e |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Low-dose naltrexone for the treatment of fibromyalgia: protocol for a double-blind, randomized, placebo-controlled trial
por: Karin Due Bruun, et al.
Publicado: (2021) -
Slow temporal summation of pain for assessment of central pain sensitivity and clinical pain of fibromyalgia patients.
por: Roland Staud, et al.
Publicado: (2014) -
Anxiety enhances pain in a model of osteoarthritis and is associated with altered endogenous opioid function and reduced opioid analgesia
por: Amanda Lillywhite, et al.
Publicado: (2021) -
Sexual dysfunction, mood, anxiety, and personality disorders in female patients with fibromyalgia
por: Kayhan F, et al.
Publicado: (2016) -
Fibromyalgia: The underdiagnosed disease of pain
por: Consuelo Rivera-Miranda Giral, et al.
Publicado: (2021)